Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,161 | 440 | 88.1% |
| Travel and Lodging | $2,041 | 8 | 11.1% |
| Education | $151.07 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $3,306 | 25 | $0 (2023) |
| Cook Medical LLC | $2,349 | 64 | $0 (2023) |
| Medtronic Vascular, Inc. | $1,858 | 34 | $0 (2019) |
| Philips Electronics North America Corporation | $1,790 | 28 | $0 (2023) |
| Cook Incorporated | $985.71 | 11 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $866.18 | 37 | $0 (2021) |
| Surmodics, Inc. | $784.03 | 10 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $727.62 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $658.48 | 33 | $0 (2024) |
| Medtronic, Inc. | $532.99 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,000 | 41 | Novartis Pharmaceuticals Corporation ($212.86) |
| 2023 | $1,689 | 25 | Surmodics, Inc. ($784.03) |
| 2022 | $1,530 | 31 | Philips Electronics North America Corporation ($723.54) |
| 2021 | $899.78 | 36 | Cook Medical LLC ($310.16) |
| 2020 | $621.09 | 25 | Cook Medical LLC ($235.63) |
| 2019 | $2,240 | 71 | Philips Electronics North America Corporation ($337.71) |
| 2018 | $4,500 | 114 | Cook Medical LLC ($1,345) |
| 2017 | $5,872 | 108 | Abbott Laboratories ($2,919) |
All Payment Transactions
451 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $136.79 | General |
| Category: Pacemakers | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/30/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Education | In-kind items and services | $94.99 | General |
| Category: Cardiology | ||||||
| 10/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Cardiology | ||||||
| 10/17/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Cardiology | ||||||
| 09/30/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $25.19 | General |
| 09/18/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $39.54 | General |
| Category: EndoVenous Therapies | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $7.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/03/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $58.87 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 08/28/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Cardiology | ||||||
| 08/22/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/14/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.96 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/08/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.96 | General |
| Category: Cardiovascular | ||||||
| 07/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $3.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Cardio-renal | ||||||
| 05/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Cardiology | ||||||
| 05/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,955 | 3,074 | $623,877 | $268,020 |
| 2022 | 28 | 1,813 | 2,481 | $1.2M | $538,390 |
| 2021 | 23 | 1,648 | 2,318 | $993,442 | $483,896 |
| 2020 | 20 | 1,367 | 1,853 | $785,967 | $386,163 |
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 266 | 583 | $107,855 | $59,258 | 54.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 118 | 118 | $103,014 | $46,207 | 44.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 172 | 176 | $70,928 | $25,861 | 36.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 99 | 100 | $37,000 | $14,410 | 38.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 99 | 99 | $27,866 | $13,577 | 48.7% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 57 | 62 | $25,420 | $12,904 | 50.8% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 93 | 94 | $32,900 | $12,465 | 37.9% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 118 | 153 | $17,788 | $11,740 | 66.0% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 46 | 231 | $27,983 | $8,033 | 28.7% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 33 | 34 | $18,360 | $7,021 | 38.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 48 | 155 | $18,777 | $6,727 | 35.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 122 | 122 | $16,226 | $6,515 | 40.2% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 11 | 13 | $13,780 | $5,848 | 42.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 45 | 124 | $19,162 | $5,834 | 30.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 36 | $9,000 | $5,021 | 55.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 54 | $6,750 | $4,101 | 60.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 277 | 345 | $25,875 | $4,026 | 15.6% |
| 75716 | Review by radiologist of both arms or legs arteries image | Office | 2023 | 23 | 23 | $7,850 | $3,238 | 41.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $6,300 | $2,888 | 45.8% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 23 | 29 | $7,250 | $2,771 | 38.2% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 15 | 15 | $5,400 | $2,325 | 43.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 31 | 38 | $3,610 | $1,752 | 48.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 12 | 48 | $3,384 | $1,539 | 45.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 23 | 23 | $2,300 | $1,351 | 58.7% |
| 99153 | Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | Office | 2023 | 30 | 122 | $3,050 | $1,247 | 40.9% |
About Dr. Babar Ali, MD
Dr. Babar Ali, MD is a Interventional Cardiology healthcare provider based in Takoma Park, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1952505877.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Babar Ali, MD has received a total of $18,352 in payments from pharmaceutical and medical device companies, with $1,000 received in 2024. These payments were reported across 451 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($16,161).
As a Medicare-enrolled provider, Ali has provided services to 6,783 Medicare beneficiaries, totaling 9,726 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease
- Location Takoma Park, MD
- Active Since 06/13/2007
- Last Updated 03/04/2015
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1952505877
Products in Payments
- Omnilink Elite vascular stent system (Device) $2,182
- Cook Medical Zilver PTX (Device) $815.00
- Sublime 014 Rx PTA Balloon Dilatation Catheter (Device) $784.03
- BRILINTA (Drug) $749.13
- LifeVest (Device) $727.62
- Resolute (Device) $562.66
- HawkOne (Device) $509.33
- COOK MEDICAL ZILVER PTX (Device) $495.68
- Supera peripheral stent system (Device) $455.85
- IN.PACT Admiral (Device) $419.62
- ENTRESTO (Drug) $397.00
- (4066) Tack Endo Sys ATK (Device) $374.76
- Cook Medical Angioplasty (Device) $363.01
- Repatha (Biological) $354.78
- COOK MEDICAL STENTS (Device) $352.82
- ELIQUIS (Drug) $351.79
- XARELTO (Drug) $345.59
- (6554) Peripheral Vascular Undivided (Device) $274.13
- VIABAHN Endoprosthesis with PROPATEN Bioactive Surface (Device) $271.21
- LEQVIO (Drug) $261.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.